United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 3 minute read Pharma Industry News Regeneron Pharmaceuticals’ Inmazeb FDA approval: A milestone in Ebola treatment Regeneron Pharmaceuticals has achieved a significant breakthrough with the approval of its antibody cocktail, Inmazeb (atoltivimab, maftivimab, and… bypharmanewsdailyOctober 15, 2020
